Efficacy of troglitazone measured by insulin resistance index [2]

Lancet

Volumn 350, Issue 9072, 1997, Pages 184-

  Nagasaka, Shoichiro ^a   Iwamoto, Yasuhiko ^b   Ishikawa, San e ^b   Kuzuya, Takeshi ^b   Saito, Toshikazu ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; TROGLITAZONE;

ADULT; BODY MASS; CLINICAL ARTICLE; CORRELATION FUNCTION; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0342711253     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62350-1     Document Type: Article

References (5)

1. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-19.
2. Duncan MH, Singh BM, Wise PH, et al. A simple measure of insulin resistance. Lancet 1995; 346: 120-21.
3. Iwamoto Y, Kosaka K, Kuzuya T, et al. Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy. Diabetes Care 1996; 19: 151-56.
4. Kumar S, Boulton AJM, Beck-Nielsen H, et al. Troglitazone, an insulin enhancer, improves metabolic control in NIDDM patients. Diabetologia 1996; 39: 701-09.
5. Cleland SJ, Petrie JR, Morris AD, et al. FIRI: a fair insulin resistance index? Lancet 1996; 347: 770.